The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Dose-response modelling of endemic coronavirus and SARS-CoV-2: human challenge trials reveal the individual variation in susceptibility

    1. Fuminari Miura
    2. Don Klinkenberg
    3. Jacco Wallinga

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. COVID-19 in the Mexican Social Security Institute (IMSS) population. Prevalent symptoms

    1. Arturo Juárez-Flores
    2. Iván J. Ascencio-Montiel
    3. Juan Pablo Gutiérrez
    4. Stefano M. Bertozzi
    5. Víctor H. Borja-Aburto
    6. Gustavo Olaiz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Making maternity and neonatal care personalised in the COVID-19 pandemic: Results from the Babies Born Better survey in the UK and the Netherlands

    1. Lauri M. M. van den Berg
    2. Naseerah Akooji
    3. Gill Thomson
    4. Ank de Jonge
    5. Marie-Clare Balaam
    6. Anastasia Topalidou
    7. Soo Downe
    8. on behalf of the ASPIRE COVID-19 research team

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study

    1. Hong Zheng
    2. Yunlong Cao
    3. Xiaosu Chen
    4. Fengmei Wang
    5. Ye Hu
    6. Weiliang Song
    7. Yangyang Chai
    8. Qingqing Gu
    9. Yansong Shi
    10. Yingmei Feng
    11. Shuxun Liu
    12. Yan Xie
    13. Xiaoliang Sunney Xie
    14. Wentao Jiang
    15. Zhongyang Shen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients

    1. Grégory Destras
    2. Antonin Bal
    3. Bruno Simon
    4. Bruno Lina
    5. Laurence Josset

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. To mask, or not to mask, Alice and Bob’s dating dilemma

    1. Zhanshan (Sam) Ma
    2. Ya-Ping Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 2 listsLatest version Latest activity

  7. Dynamics of anti-spike IgG antibody after a third BNT162b2 COVID-19 vaccination in Japanese health care workers

    1. Hiroaki Ikezaki
    2. Hideyuki Nomura
    3. Nobuyuki Shimono

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US

    1. Raynell Lang
    2. Elizabeth Humes
    3. Sally B. Coburn
    4. Michael A. Horberg
    5. Lily F. Fathi
    6. Eric Watson
    7. Celeena R. Jefferson
    8. Lesley S. Park
    9. Kirsha S. Gordon
    10. Kathleen M. Akgün
    11. Amy C. Justice
    12. Sonia Napravnik
    13. Jessie K. Edwards
    14. Lindsay E. Browne
    15. Deana M. Agil
    16. Michael J. Silverberg
    17. Jacek Skarbinski
    18. Wendy A. Leyden
    19. Cameron Stewart
    20. Brenna C. Hogan
    21. Kelly A. Gebo
    22. Vincent C. Marconi
    23. Carolyn F. Williams
    24. Keri N. Althoff
    25. Corona-Infectious-Virus Epidemiology Team (CIVETs) of the NA-ACORD of IeDEA

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Effectiveness of COVID-19 mRNA vaccine booster dose relative to primary series during a period of Omicron circulation

    1. Joshua G. Petrie
    2. Jennifer P. King
    3. David L. McClure
    4. Melissa A. Rolfes
    5. Jennifer K. Meece
    6. Edward A. Belongia
    7. Huong Q. McLean

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing

    1. Sigrun Hallmeyer
    2. Michael A Thompson
    3. Veronica Fitzpatrick
    4. Yunqi Liao
    5. Michael P Mullane
    6. Stephen C Medlin
    7. Kenneth Copeland
    8. James L Weese

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 517 of 2361 Older